0000000001331505

AUTHOR

C Marino

showing 5 related works from this author

An algorithm for the assessment of subjective adaptive thermal comfort conditions based on multi-agent systems

2011

Thermal comfort conditions in the built environment are strictly related not only to the thermal and geometric building features and to air-conditioning systems, but also to the building destination, to its using profile and to the biological-metabolic-psychological characteristics of users. As a consequence, there is a strong claim for new models, both subjective and adaptive to the environment, in a particular holistic vision of the problem, with regards to the novel tern user-plant-building system. In such a frame, through the paper the characterization of an algorithm aimed at subjective adaptive thermal comfort evaluations, enriching the one proposed by Fanger with an adaptive approach…

adaptive thermal comfortmulti-agent systemintelligent agents.
researchProduct

Multi-Agent Systems as Effective Tools for the User-Based Thermal Comfort: an Introduction

2010

Through the paper the characterization of a comfort model, enriching that proposed by Fanger with an adaptive approach, is carried out using a Multi Agent System (MAS). This is a well suited coordinated set of Intelligent Agents, that are software applications interacting in order to follow user in his own needs and preferences in relation to indoor comfort, adapting to the changes of context variables. As a matter of fact, MAS are systems aware of the scenery where users live, following them in their own needs and preferences and adapting to their expectations. Indeed, thermal comfort conditions in the built environment are strictly related not only to the thermal and geometric building fe…

Settore ING-IND/11 - Fisica Tecnica AmbientaleUser behaviourIndoor thermal comfortAdaptative subjective approachlntelligent agentsHolistic comfort
researchProduct

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately …

2017

Background The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We aimed to compare the long-term effects of pioglitazone versus sulfonylureas, given in addition to metformin, on cardiovascular events in patients with type 2 diabetes. Methods TOSCA.IT was a multicentre, randomised, pragmatic clinical trial, in which patients aged 50–75 years with type 2 diabetes inadequately controlled with metformin monotherapy (2–3 g per day) were recruited from 57 diabetes clinics in Italy. Patients were randomly assigned (1:1), by permuted blocks randomisation (block size 10), stratified by site and…

MaleDiabetes and Metabolism ipoglycemic drugs cardiovascualr eventSettore MED/09 - Medicina Internaendocrine system diseasesIMPACTpioglitazone versus sulfonylureasEndocrinology Diabetes and MetabolismGLIMEPIRIDEDiabetes cardiovascular events metformin pioglitazone sulphonylureasType 2 diabetes030204 cardiovascular system & hematologyInternal Medicine; Endocrinology Diabetes and Metabolism; Endocrinologylaw.inventionSettore MED/13 - EndocrinologiaGlibenclamide0302 clinical medicineRandomized controlled triallawGLYCEMIC CONTROLGliclazideInternal medicinediabetes and metabolismRISKeducation.field_of_studydiabetesIncidenceInternal medicine; endocrinology diabetes and metabolism; endocrinologyMiddle AgedINSULINMetforminMetforminTreatment OutcomeEditorialsulphonylureasCardiovascular DiseasesCombinationDrug Therapy CombinationFemaleType 2medicine.drugmedicine.medical_specialtyPopulation030209 endocrinology & metabolismAged; Cardiovascular Diseases; Diabetes Mellitus Type 2; Drug Therapy Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment OutcomeCardiovascular events03 medical and health sciencesendocrinologyGLUCOSE-LOWERING DRUGSDrug TherapyInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentssulfonylureaseducationTOSCA.ITAgedPioglitazonebusiness.industryMORTALITYnutritional and metabolic diseasesInsulin resistancemedicine.diseaseSurgeryGlimepirideSulfonylurea CompoundsDiabetes Mellitus Type 2Diabetes Mellitus; Pioglitazone; Insulin resistanceThiazolidinedionesbusinessFOLLOW-UPPioglitazone
researchProduct

Turismo inbound e ricettività in Sicilia: un’analisi della distribuzione spaziale

2010

In the last few years a significant increase in tourist accommodation has taken place in Sicily, both in hotels and in other hospitality. The increased number of accommodation beds has been encouraged by a multilevel policy of investments – both regional and European – aimed at filling the qualitative and quantitative gap penalizing Sicily in the field of tourism and accommodation competition. In some way, it may seem that the purpose of improving the accommodation supply in our Island has been obtained: indeed, while in 2000, the year when the previous European planning started, the number of accommodation beds in hotels was, in Sicily, of 4,2% of the national amount, in 2008 the Island ra…

inbound tourism accommodation capacity spatial distribution POR Sicilia 2000-2006
researchProduct

Immanuel Kant. Il tempo interno del miglioramento: un paradigma del progresso storico?

2010

Il soggetto kantiano, per sapersi morale, deve potersi pensare come un soggetto che non ha fine nel tempo sensibile: per pensarsi secondo questa forma dell’intelligibile egli postula una durata infinita della sua personalità. Con ciò si apre un orizzonte di senso immaginabile soltanto in un ‘futuro aperto’ e dilatato all’infinito: in questa dimensione temporale specifica trova senso l’esercizio morale di ogni individuo. La designazione temporale dell’immortalità dell’anima come durata infinita (unendliche Dauer) e il progresso intelligibile che è connesso al postulato mostrano un’interessante processualità inerente alla dimensione intelligibile - non spazio-temporalmente condizionata - dell…

I. KantVerbesserungimmortalità dell'animadurata.progresso intelligibilenoumenoI. Kant; Verbesserung; immortalità dell'anima; progresso; noumeno; progresso intelligibile; durata.progresso
researchProduct